These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 15835505)

  • 1. Infections and their treatment in older people.
    Banning M
    Nurs Older People; 2005 Apr; 17(2):25-9; quiz 30. PubMed ID: 15835505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The efficacy of cefditoren pivoxil in the treatment of lower respiratory tract infections, with a focus on the per-pathogen bacteriologic response in infections caused by Streptococcus pneumoniae and Haemophilus influenzae: a pooled analysis of seven clinical trials.
    Granizo JJ; Giménez MJ; Barberán J; Coronel P; Gimeno M; Aguilar L
    Clin Ther; 2006 Dec; 28(12):2061-9. PubMed ID: 17296462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Community-acquired upper respiratory tract infections and the role of third-generation oral cephalosporins.
    Hedrick JA
    Expert Rev Anti Infect Ther; 2010 Jan; 8(1):15-21. PubMed ID: 20014898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [beta-lactam-antibiotics in the treatment of community-acquired respiratory tract infections with penicillin-resistant pneumococci].
    Brauers J; Ewig S; Kresken M
    Pneumologie; 2002 Oct; 56(10):605-9. PubMed ID: 12375222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A review of Streptococcus pneumoniae infection treatment failures associated with fluoroquinolone resistance.
    Fuller JD; Low DE
    Clin Infect Dis; 2005 Jul; 41(1):118-21. PubMed ID: 15937772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serotype distribution and antimicrobial resistance patterns in Streptococcus pneumoniae isolates from hospitalized pediatric patients with respiratory infections in Shanghai, China.
    Zhao GM; Black S; Shinefield H; Wang CQ; Zhang YH; Lin YZ; Lu JL; Guo YF; Jiang QW
    Pediatr Infect Dis J; 2003 Aug; 22(8):739-42. PubMed ID: 12913778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of coamoxiclav and other antibiotics against S pneumoniae and H influenae from paediatric cases of acute respiratory infections.
    Krishnan P; Rajendran P; Sambandan AP; Anitha C; Chavda RK; Khobragade KJ
    J Indian Med Assoc; 2011 Apr; 109(4):241-2, 244. PubMed ID: 22187795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treating respiratory tract infections in ambulatory care in Belgium: fluoroquinolone consumption and resistance development.
    Simoens S; Verhaegen J; Laekeman G; Peetermans WE
    Int J Antimicrob Agents; 2005 Jul; 26(1):62-8. PubMed ID: 15963695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New fluoroquinolones in lower respiratory tract infections and emerging patterns of pneumococcal resistance.
    Ferrara AM
    Infection; 2005 Jun; 33(3):106-14. PubMed ID: 15940410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Doxycycline use for community-acquired pneumonia: contemporary in vitro spectrum of activity against Streptococcus pneumoniae (1999-2002).
    Jones RN; Sader HS; Fritsche TR
    Diagn Microbiol Infect Dis; 2004 Jun; 49(2):147-9. PubMed ID: 15183865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical impact of antibiotic resistance in respiratory tract infections.
    Klugman KP
    Int J Antimicrob Agents; 2007 Feb; 29 Suppl 1():S6-10. PubMed ID: 17307654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cefditoren and community-acquired lower respiratory tract infections (corrected)].
    Barberán J; Mensa J
    Rev Esp Quimioter; 2009 Sep; 22(3):144-50. PubMed ID: 19662548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resistant pneumococcal infections.
    Koornhof HJ; Jacobs MR
    Compr Ther; 1979 May; 5(5):69-74. PubMed ID: 37022
    [No Abstract]   [Full Text] [Related]  

  • 14. [Empyema: bacterial epidemiology and antibiotic resistance].
    Vu-Thien H
    Arch Pediatr; 2008 Oct; 15 Suppl 2():S81-3. PubMed ID: 19000860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Understanding the burden of pneumococcal disease in adults.
    Blasi F; Mantero M; Santus P; Tarsia P
    Clin Microbiol Infect; 2012 Oct; 18 Suppl 5():7-14. PubMed ID: 22882668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microbiological and pharmacodynamic considerations in the treatment of infection due to antimicrobial-resistant Streptococcus pneumoniae.
    Appelbaum PC
    Clin Infect Dis; 2000 Aug; 31 Suppl 2():S29-34. PubMed ID: 10984325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Respiratory tract infection: epidemiology and surveillance.
    Jacobs MR
    J Chemother; 1997 May; 9 Suppl 3():10-7. PubMed ID: 9248976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prevalence and treatment for antibiotic-resistant bacteria in respiratory infection].
    Watanuki Y
    Nihon Rinsho; 2007 Feb; 65 Suppl 2 Pt. 1():502-7. PubMed ID: 17455671
    [No Abstract]   [Full Text] [Related]  

  • 19. Antibiotic-resistant Streptococcus pneumoniae. Implications for medical practice.
    Wang EE; Kellner JD; Arnold S
    Can Fam Physician; 1998 Sep; 44():1881-8. PubMed ID: 9789668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial selection for community-acquired lower respiratory tract infections in the 21st century: a review of gemifloxacin.
    Appelbaum PC; Gillespie SH; Burley CJ; Tillotson GS
    Int J Antimicrob Agents; 2004 Jun; 23(6):533-46. PubMed ID: 15194123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.